Buscar
🇪🇸
MEM
O
RY
.COM
4.37.48
Invitado
Iniciar sesión
Página de inicio
0
0
0
0
0
Crear curso
Cursos
Último juego
Panel
Notificaciones
Clases
Carpetas
Exámenes
Exámenes personalizados
Ayuda
Marcador
Tienda
Premios
Amigos
Asignaturas
Modo oscuro
Identificador de usuario: 999999
Versión: 4.37.48
www.memory.es
Estás en modo de exploración. debe iniciar sesión para usar
MEM
O
RY
Inicia sesión para empezar
Index
»
Female Reproductive Tract Pathology
»
Chapter 1
»
Moderate
level: Moderate
Questions and Answers List
level questions: Moderate
Question
Answer
characteristics of high-grade cervical dysplasia
hyperchromatic nuclei and high nuclear cytoplasmic ratios
most important predictor for progression of endometrial hyperplasia to carcinoma
cellular atypia
histological classification of endometrial hyperplasia is based on what factors?
architectural growth pattern and presence or absence of cellular atypia
limitations of Pap smear
inadequate sampling of the transformation zone and limited efficacy in screening for adenocarcinoma
pathogenesis of anovulatory cycle
estrogen-driven proliferatve phase without a subsequent progesterone-driven secretory phase
drug previously used for management of threatened abortion but was withdrawn due to increased risk of adenosis and clear cell adenocarcinoma in females exposed in utero
diethylstilbestrol
drug that has an anti-estrogenic effect on the breast but pro-estrogenic effect on the endometrium
tamoxifen
most common cause of mental retardation and also leads to facial abnormalities and microcephaly
alcohol
illegal drug that cause IUGR and placental abruption
cocaine
therapeutic drug withdrawn due to limb defects
thalidomide
drug that causes spotaneous abortion, hearinig and visual impairment in fetus
Isoretinoin
drug that causes discolored teeth
Tetracycline
anticoagulant that causes fetal bleeding
Warfarin
antiseizure medication which causes digit hypoplasia and cleft lip/palate
Phenytoin
most common age group affected by cervical carcinoma
middle aged women (40-50 years)
average number of years before CIN develops into carcinoma
10-20 years
how low does the quadrivalent vaccine last?
5 years
age group of leiomyoma
premenopausal women
age group of leiomyosarcoma
postmenopausal women
most common age group of granulosa-theca cell tumors
postmenopausal women
incidence of surface epithelial cells
70%
age group of cystadenomas
30-40 years old
age group of cystadenocarcinomas
60-70 years old